The present invention relates to a solid orally administrable pharmaceutical dosage form comprising 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl} methyl)-2-thiophene¬carboxamide (I), characterized in that it consists of a combination of rapid and controlled release, where the active compound dose with controlled release is incorporated into an osmotic two-chamber system, and the osmotic release system is combined with an active compound-comprising film coating with rapid release of active compound (I) or an active compound-comprising mantle formed from powder or granules (core/mantle tablet). The present invention also relates to a process for preparing the solid orally administrable pharmaceutical dosage form, a medicament comprising the solid orally administrable pharmaceutical dosage form, and uses of the solid orally administrable pharmaceutical dosage form.
